DiaSorin develops and markets in vitro diagnostic systems and reagents, with a focus on immunodiagnostics and molecular diagnostics. Its automated platforms and specialty test menus are used by clinical laboratories for infectious disease, hormone, oncology and other specialty assays. The company is known for niche, high-value diagnostic tests rather than broad routine chemistry volumes.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 313 | — | 52 | — |
| Q2 2025 | 306.3 | — | 47.4 | — |
All markets — KeepWinning global stock screener
Other companies on Borsa Italiana (Milan): Iveco Group N.V. (IVG), ERG S.p.A. (ERG), Danieli & C. Officine Meccaniche S.p.A. (DANR), Iren SpA (IRE), Carel Industries S.p.A. (CRL), ENAV S.p.A. (ENAV)